Savara Pharmaceuticals
SVRA
#7060
Rank
โ‚ฌ0.41 B
Marketcap
2,40ย โ‚ฌ
Share price
1.22%
Change (1 day)
-49.15%
Change (1 year)

Earnings for Savara Pharmaceuticals (SVRA)

Earnings in 2024 (TTM): -โ‚ฌ75.87 Million

According to Savara Pharmaceuticals's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -โ‚ฌ52.62 Million a decrease over its 2022 earnings that were of -โ‚ฌ36.7 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Savara Pharmaceuticals from 2002 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -โ‚ฌ75.87 Million44.17%
2023 -โ‚ฌ52.62 Million43.38%
2022 -โ‚ฌ36.7 Million-11.31%
2021 -โ‚ฌ41.38 Million-13.3%
2020 -โ‚ฌ47.73 Million-36.53%
2019 -โ‚ฌ75.21 Million13.76%
2018 -โ‚ฌ66.11 Million105.54%
2017 -โ‚ฌ32.17 Million34.11%
2016 -โ‚ฌ23.99 Million-37.43%
2015 -โ‚ฌ38.33 Million38.81%
2014 -โ‚ฌ27.62 Million33.62%
2013 -โ‚ฌ20.67 Million38.49%
2012 -โ‚ฌ14.93 Million24.59%
2011 -โ‚ฌ11.98 Million-36.5%
2010 -โ‚ฌ18.86 Million-3.14%
2009 -โ‚ฌ19.48 Million-23.28%
2008 -โ‚ฌ25.38 Million8.52%
2007 -โ‚ฌ23.39 Million-34.14%
2006 -โ‚ฌ35.52 Million184.43%
2005 -โ‚ฌ12.49 Million90.75%
2004 -โ‚ฌ6.55 Million190.35%
2003 -โ‚ฌ2.26 Million11.64%
2002 -โ‚ฌ2.02 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-โ‚ฌ17.47 Million-78.11%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚ฌ0.12 Billion 42.09%๐Ÿ‡บ๐Ÿ‡ธ USA